To foster and increase public awareness and education regarding the diagnosis, management and treatment of cold agglutinin disease. In return, this will cause a continuously improving system of education, information and opportunities for those diagnosed or treating patients with cold agglutinin disease.
Main program · fiscal year 2025
The organization increases awareness and education about cold agglutin disease through online resources. This has been aiding in the advancement of knowledge for the medical profession, patients, and care partners.$18,486 spent
Where each dollar went · fiscal year 2025
Of every dollar it spent, 81¢ went to programs, 19¢ to management and 0¢ to fundraising.
Programs $18,486
Management $4,369
Fundraising $0
In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.
Operating reserves (reduced: more than 3 years of cash)
10+ yrs; 10+ yrs in cash
0 / 25
Financial balance (median margin)
+124.7%
3.8 / 20
Transparency
4 full 990s, latest TY2025
20 / 20
Program growth
−28.5% / yr
0 / 15
Track record
7 years
2.8 / 10
Debt load
0.0% of assets
10 / 10
Total
36.6 → 37
Spending on programs Not scored; America's Best needs 65%+
81%
Meets
Tax filings by year
Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.
Revenue$84,576Fiscal year 2025
Expenses$22,855Fiscal year 2025
Total assets$272,508Fiscal year 2025
Total liabilities$0Fiscal year 2025
Fiscal year ending December2025
Revenue$84,576
Expenses$22,855
Net income$61,721
Net assets$272,508
Notable sources of revenue
Percent of total revenue
Contributions
$84,576
100.0%
Program services
$0
0.0%
Investment income
$0
0.0%
Other (net)
$0
0.0%
Assets / debt
Total assets
$272,508
Total liabilities
$0
Net assets
$272,508
Compensation
Not in our extract for this year.
Fiscal year ending December2024
Revenue$12,558
Expenses$25,445
Net income−$12,887
Net assets$210,787
Notable sources of revenue
Percent of total revenue
Contributions
$12,558
100.0%
Program services
$0
0.0%
Investment income
$0
0.0%
Other (net)
$0
0.0%
Assets / debt
Total assets
$210,787
Total liabilities
$0
Net assets
$210,787
Compensation
Not in our extract for this year.
Fiscal year ending December2023
Revenue$107,336
Expenses$38,974
Net income$68,362
Net assets$223,674
Notable sources of revenue
Percent of total revenue
Contributions
$81,976
76.4%
Program services
$25,360
23.6%
Investment income
$0
0.0%
Other (net)
$0
0.0%
Assets / debt
Total assets
$223,674
Total liabilities
$0
Net assets
$223,674
Compensation
Not in our extract for this year.
Fiscal year ending December2022
Revenue$108,579
Expenses$62,415
Net income$46,164
Net assets$155,312
Notable sources of revenue
Percent of total revenue
Contributions
$108,579
100.0%
Program services
$0
0.0%
Investment income
$0
0.0%
Other (net)
$0
0.0%
Assets / debt
Total assets
$155,312
Total liabilities
$0
Net assets
$155,312
Compensation
Officers and key employees
$0
Share of expenses
0.0%
About this data
Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?